Postoperative pain
Conditions
Interventions
Trade Name: Catepressan
Product Name: CATAPRESAN
Pharmaceutical Form: Solution for injection/infusion
INN or Proposed INN: CLONIDINE
CAS Number: 4205-90-7
Concentration unit: mg milligram(s)
Concentra
Sponsors
Sint Antonius Ziekenhuis
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients above 18 years of age who undergo foot/anckle surgery Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 120 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Neuropathy, chronic pain and allergy to substance used.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Duration of loco-regional anesthesia ;Secondary Objective: Postoperative pain, patient satisfaction;Primary end point(s): Duration of block; postoperative pain;Timepoint(s) of evaluation of this end point: Painscores mmediately after surgery and at 18.00 and 21.00 on the day of surgery. At 8.00 on the 1st postoperative day. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): Patient satisfaction; nausea; hypotension; sedation;Timepoint(s) of evaluation of this end point: mmediately after surgery and at 18.00 and 21.00 on the day of surgery. At 8.00 on the 1st postoperative day. | — |
Countries
Netherlands
Contacts
Public ContactP.A. Ramsodit
Sint Antonius Ziekenhuis
Outcome results
None listed